Carson Wealth (CWM LLC)
ATYR

Carson Wealth (CWM LLC)’s aTyr Pharma ATYR Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.1K Buy
36,010
+28,032
+351% +$23.7K ﹤0.01% 4215
2025
Q4 		$6K Buy
7,978
+7,959
+41,889% +$6.53K ﹤0.01% 4784
2025
Q3 		$0 Buy
+19
New +$86 ﹤0.01% 5605

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ATYR Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its aTyr Pharma (ATYR) stake by 351% in Q1 2026, buying an estimated $23.7K and bringing the position to 36,010 shares worth $28.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4215.

Carson Wealth (CWM LLC) first reported a position in ATYR in Q3 2025 and has held it in 3 quarters since. 111 funds tracked by Wall St. Rank hold ATYR as of Q1 2026.

  • Carson Wealth (CWM LLC) held 36,010 shares of aTyr Pharma worth $28.1K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 28,032 aTyr Pharma shares in Q1 2026, an estimated $23.7K.
  • aTyr Pharma made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4215 holding.
  • Carson Wealth (CWM LLC) first reported a position in aTyr Pharma in Q3 2025 and has held it in 3 quarters since.
  • 111 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.